PXMD Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own PXMD shares is 1, representing 4.42% of the company's common stock.

CITADEL ADVISORS LLC, in the last quarter, reduced its stake in PXMD by -100% restricting it's holding to 0 shares of worth nearly -. HRT FINANCIAL LP also lessened -58.54% of the PXMD shares from its portfolio, reducing its holding to 10.77 thousand shares of worth $3.00K. N/A also shunned PXMD shares holding by N/A last quarter which brought its holding to - shares worth -.

As per its latest 13F filing, SUSQUEHANNA INTERNATIONAL GROUP, LLP increased its stake in PXMD by 100% in the last quarter. The institutional holder raised its holding to 31.03 thousand shares having worth more than $9.22K. RENAISSANCE TECHNOLOGIES LLC also added 100% more shares of PXMD to its portfolio, raising its holding to 97.1 thousand shares of worth $28.00K. CLEARSTEAD ADVISORS, LLC also increased its PXMD shares holding by 100% which brought its holding to 38.16 thousand shares worth $10.92K.

The insider with the most stakes in PXMD is TardiMed Sciences LLC , at the company. Additionally, PXMD stock is highly held by Chief Executive Officer Weisman Howard J. and 10 percent owner Derby Michael among others.

Company executives, directors, and other insiders own 9.01% percent of PaxMedica, Inc. Common Stock's stock. Within the last six months, there have been 0 transaction(s) in which PXMD insiders have sold stock, totaling 0 shares. Insiders that have sold shares include COELHO JOHN F, LAROCHELLE KAREN, and ROME ZACHARY.

There have been 0 transaction(s) during the past 6-months in which PaxMedica, Inc. Common Stock insiders have bought stock, totalling 0 shares

Around 0 PaxMedica, Inc. Common Stock shares are held by insiders, which represents about 9.01% of PXMD stock.

PXMD , TardiMed Sciences LLC holds the largest portfolio of the company's shares. PXMD shares owned by TardiMed total nearly 7.34 million.

SUSQUEHANNA INTERNATIONAL GROUP, LLP is the largest institutional owner in PXMD which holds 31.03 thousand shares worth $9.22K or 0.21% of the total PXMD shares outstanding followed by VANGUARD GROUP INC with ownership of 54.96 thousand shares representing 0.37% of the PXMD ownership. RENAISSANCE TECHNOLOGIES LLC is the third largest stakeholder with 97.1 thousand shares or 0.66% of the ownership worth more than $28.00K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the PXMD is concerned, it is a stock which is not optionable.

Number of PXMD shares short is 637.72K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 10.88M shares of PXMD are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, PXMD has 10.36M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for PXMD is 0.1.